Telehealth Effectively Diagnoses / Manages Fetal Congenital Heart Disease in Rural Patients

A recent study of 368 pregnant mothers, led by Bettina Cuneo, MD, director of perinatal cardiology and fetal cardiac telemedicine at Children's Hospital Colorado, found that fetal congenital heart disease (CHD) was correctly identified and successfully managed according to evidence-based risk stratification. In addition, parents achieved a dramatic cost benefit and patient/physician satisfaction was high.

This study, which was performed in conjuiction with St. Mary's Maternal Fetal Medicine and OBGYN Clinic, which is about 250 miles and two mountain passes away from the Children's Hospital Colorado's Heart Institute, is the first to look at the effects of a telecardiology program on the detection and risk stratification of fetal CHD in a medically underserved area. The program used real-time video consultation between medical experts in the clinic and pediatric cardiologists at Children's Hospital Colorado.

"With these findings, we can now confidently say that neither diagnostic quality nor patient satisfaction were sacrificed with telecardiology as opposed to in-person visits," said Dr. Cuneo. "The study also suggests that a telecardiology program is feasible and has economic advantages for the parents while keeping care close to home."

Specific findings include:

  • Obstetric sonographers who participated in the study improved their identification of fetal CHD;
  • Mothers who are carrying a fetus with suspected CHD were seen the same day even if outside the virtual clinic hours;
  • All mothers preferred their fetal cardiac evaluation to take place locally rather than traveling to the distant center;
  • The estimated total cost to parents for fetal cardiac evaluation at the distant center was 10-times greater than that of telecardiology; and
  • 100% of pregnancies with fetal CHD were correctly risk stratified

CHD is the most common birth defect and a significant cause of perinatal morbidity and mortality. Prenatal diagnosis of CHD helps ensure the optimal delivery site for the mother and baby. For example, a fetus identified with CHD that requires immediate intervention may benefit from delivery at a cardiac center of excellence, while those with stable CHD may safely deliver at a community hospital. This anticipatory care improves postnatal outcomes and effectively utilizes medical resources by delivering low-risk fetuses locally.

"While 90% of pregnant women in the United States receive at least one ultrasound during their pregnancy, fewer than 50% of infants with CHD requiring immediate postnatal intervention are diagnosed before birth," said Dr. Cuneo. "Since the lowest CHD detection rates are in rural and medically underserved areas, we are thrilled to show that telecardiology programs can effectively diagnose and manage CHD cases in those communities."

Bettina Cuneo, Christina Olson, Caitlin Haxel, Lisa Howley, Amy Gagnon, D Benson, Alexander Kaizer, J Thomas.
Risk Stratification of Fetal Cardiac Anomalies in an Underserved Population Using Telecardiology.
Obstetrics & Gynecology. 134(5):1096–1103, NOVEMBER 2019. doi: 10.1097/AOG.0000000000003502.

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

Refining Breast Cancer Classification by…

Breast cancer progression can vary significantly between patients. Even within the same tumor, different areas may be composed of different types of cells and characterized by different tumor structures. This...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...